Publications by authors named "Shonda Foster"

Claim this Profile
R
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).
Joshua A Tobin, Shivang Joshi, Janet H Ford, Russell M Nichols, Shonda A Foster

J Med Econ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct cost and healthcare resource utilization of patients with migraine before treatment initiation with calcitonin gene-related peptide monoclonal antibodies by the number of prior preventive migraine medication classes.
Shonda A Foster, Margaret Hoyt, Wenyu Ye, Oksana Mason, Janet H Ford

Curr Med Res Opin· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm.
Leslie Citrome, Margarita Sánchez Del Rio, Yan Dong, Russell M Nichols, Antje Tockhorn-Heidenreich, Shonda A Foster

Adv Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study.
Shonda A Foster, Bridget L Balkaran, M Janelle Cambron-Mellott, Karen Samaan, Oksana Mason

Curr Med Res Opin· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database.
Shonda A Foster, Chi-Chang Chen, Yao Ding, Oksana Mason, Catherine B McGuiness

J Med Econ· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe.
Janet H Ford, Shonda A Foster, Russell M Nichols, Antje Tockhorn-Heidenreich, Wenyu Ye

J Patient Rep Outcomes· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims database.
Janet H Ford, Krista Schroeder, Dawn C Buse, Shivang Joshi, Steven Gelwicks, Shonda A Foster

Curr Med Res Opin· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey.
Janet H Ford, Wenyu Ye, Russell M Nichols, Shonda A Foster, David R Nelson

J Med Econ· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.
Janet H Ford, Krista Schroeder, Allen W Nyhuis, Shonda A Foster, Sheena K Aurora

J Manag Care Spec Pharm· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
Adrienne M Gilligan, Shonda A Foster, Amy Sainski-Nguyen, Robert Sedgley, David Smith

J Occup Environ Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.
Janet H Ford, Shonda A Foster, Virginia L Stauffer, Dustin D Ruff, Sheena K Aurora

Patient Prefer Adherence· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization.
April W Armstrong, Shonda A Foster, Brian S Comer, Chen-Yen Lin, William Malatestinic

BMC Dermatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.
Sarah Al Sawah, Shonda A Foster, Russel Burge, David Amato, Alexander Schacht

J Med Econ· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
Steven R Feldman, Shonda A Foster, Baojin Zhu, Russel Burge, Sarah Al Sawah

J Drugs Dermatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
Sarah Al Sawah, Shonda A Foster, Orin M Goldblum, William N Malatestinic, Baojin Zhu

J Med Econ· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis.
Shonda A Foster, Baojin Zhu, Jiaying Guo, Enkeleida Nikai, Clement Ojeh

J Manag Care Spec Pharm· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.
Shonda A Foster, Emily F Shortridge, Marco DiBonaventura, Lars Viktrup

World J Urol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort.
Sarah Al Sawah, Xiang Zhang, Baojin Zhu, Laurence S Magder, Shonda A Foster

Lupus Sci Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey.
Shonda A Foster, Kathy Annunziata, Emily F Shortridge, Deborah Freedman, Lars Viktrup

Curr Med Res Opin· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis and treatments in Japan: management for preventing subsequent fractures.
Shuko Nojiri, Russel T Burge, Jennifer A Flynn, Shonda A Foster, Hideaki Sowa

J Bone Miner Metab· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractures in women treated with raloxifene or alendronate: a retrospective database analysis.
Shonda A Foster, Nianwen Shi, Suellen Curkendall, John Stock, Bong-Chul Chu

BMC Womens Health· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.
Leslie Hazel-Fernandez, Anthony M Louder, Shonda A Foster, Claudia L Uribe, Russel T Burge

BMC Musculoskelet Disord· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization.
Richard M Bergenstal, Jessie L Fahrbach, Şerban R Iorga, Ying Fan, Shonda A Foster

Endocr Pract· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The direct and indirect costs among U.S. privately insured employees with hypogonadism.
Anna Kaltenboeck, Shonda Foster, Jasmina Ivanova, Melissa Diener, Rachel Bergman

J Sex Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of insulin therapies and associated delivery systems.
Lauren J Lee, Lee J Smolen, Timothy M Klein, Shonda A Foster, Doug Whiteman

Am J Health Syst Pharm· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis